Publications

De Diego Balaguer, R., Toro, J., Rodríguez-Fornells, A. & Bachoud-Levi, A. (2007). Different neurophysiological mechanisms underlying word and rule extraction from speech. PloS one, 2(11), e1175. doi:10.1371/journal.pone.0001175

Bartolomeo, P., Bachoud-Levi, A., Degos, J. & Boiler, F. (1998). Disruption of residual reading capacity in a pure alexic patient after a mirror-image right-hemispheric lesion. Neurology, 50(1), 286-288. doi:10.1212/WNL.50.1.286

Bachoud-Levi, A., Ergis, A., Cesaro, P. & Degos, J. (2000). Dissociation between distal and proximal left limb agraphia and agraphesthesia in a patient with a callosal disconnection syndrome. Cortex, 36(3), 351-363. doi:10.1016/S0010-9452(08)70846-3

Douaud, G., Gaura, V., Ribeiro, M., Lethimonnier, F., Maroy , R., Verny, C., Krystkowiak, P., Damier, P., Bachoud-Levi, A., Hantraye, P. & Remy, P. (2006). Distribution of grey matter atrophy in Huntington's disease patients: A combined ROI-based and voxel-based morphometric study. NeuroImage, 32(4), 1562-1575. doi:10.1016/j.neuroimage.2006.05.057

Bachoud-Levi, A., Gaura, V., Brugières, P., Lefaucheur, J., Boissé, M., Maison, P., Baudic, S., Ribeiro, M., Bourdet, C., Remy, P., Cesaro, P., Hantraye, P. & Peschanski, M. (2006). Effect of fetal neural transplants in patients with Huntington's disease 6 years after surgery: a long-term follow-up study. The Lancet. Neurology, 5(4), 303-9. doi:10.1016/S1474-4422(06)70381-7

Désaméricq, G., Dolbeau, G., Verny, C., Charles, P., Durr, A., Youssov, K., Simonin, C., Azulay, J., Tranchant, C., Goizet, C., Damier, P., Broussolle, E., Démonet, J., Morgado, G., Cleret de Langavant, L., Macquin-Mavier, I., Bachoud-Levi, A. & Maison, P. (2014). Effectiveness of anti-psychotics and related drugs in the Huntington French-speaking group cohort. PloS one, 9(1), e85430. doi:10.1371/journal.pone.0085430

Hugues, A., Guinet-Lacoste, A. , Bin, S. , Lunven, M., Pérennou, D. , Giraux, P. , Foncelle, A. , Rossetti, Y., Jacquin-Courtois, S., Luauté, J. & Rode, G. (2021). Effects of prismatic adaptation on balance and postural disorders in patients with chronic right stroke: protocol for a multicentre double-blind randomised sham-controlled trial. BMJ Open , 11(11), e052086. doi:10.1136/bmjopen-2021-052086

Cochen, V., Degos, J. & Bachoud-Levi, A. (2000). Efficiency of carbamazepine in the treatment of micturitional disturbances in Huntington disease. Neurology. doi:10.1212/wnl.55.12.1934

Lefaucheur, J., Ménard-Lefaucheur, I., Maison, P., Baudic, S., Cesaro, P., Peschanski, M. & Bachoud-Levi, A. (2006). Electrophysiological deterioration over time in patients with Huntington's disease. Movement disorders : official journal of the Movement Disorder Society, 21(9), 1350-4. doi:10.1002/mds.20966

Trinkler, I., Devignevielle, S., Achaibou, A., Ligneul, R., Brugières, P., Cleret de Langavant, L., De Gelder, B., Scahill, R., Schwartz, S. & Bachoud-Levi, A. (2017). Embodied emotion impairment in Huntington's Disease. Cortex; a journal devoted to the study of the nervous system and behavior, 92, 44-56. doi:10.1016/j.cortex.2017.02.019

Gallezot, C. , Riad, R., Titeux, H., Lemoine, L., Montillot, J., Sliwinski, A., Hamet Bagnou, J., Cao, X., Youssov, K., Dupoux, E. & Bachoud-Levi, A. (2022). Emotion expression through spoken language in Huntington Disease. Cortex. doi:10.1016/j.cortex.2022.05.024

Baudic, S., Barba, G., Thibaudet, M., Smagghe, A., Remy, P. & Traykov, L. (2006). Executive function deficits in early Alzheimer's disease and their relations with episodic memory. Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists, 21(1), 15-21. doi:10.1016/j.acn.2005.07.002

Traykov, L., Raoux, N., Latour, F., Gallo, L., Hanon, O., Baudic, S., Bayle, C., Wenisch, E., Remy, P. & Rigaud, A. (2007). Executive functions deficit in mild cognitive impairment. Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology, 20(4), 219-24. doi:10.1097/WNN.0b013e31815e6254

Mariani, L., Tesson, C., Charles, P., Cazeneuve, C., Hahn, V., Youssov, K., Freeman, L., Grabli, D., Roze, E., Noël, S., Peuvion, J., Bachoud-Levi, A., Brice, A., Stevanin, G. & Durr, A. (2016). Expanding the Spectrum of Genes Involved in Huntington Disease Using a Combined Clinical and Genetic Approach. JAMA neurology, 73(9), 1105-14. doi:10.1001/jamaneurol.2016.2215

Martín-Gómez, C., Darío Ortigoza-Escobar, J., Nou-Fontanet, L., M Molina-Linde, J., Bachoud-Levi, A., Léger, J., Antonio Blasco-Amaro, J. & Disorders Guideline Working Group, N. (2023). Exploring the values, preferences, and information needs of patients with NKX2-1-related disorders: A qualitative study protocol. PloS one, 18(2), e0281573. doi:10.1371/journal.pone.0281573

Van Der Gucht, A., Aoun-Sebaiti, M., Kauv, P., Guedj, E., Aouizerate, J., Verger, A., Gherardi, R., Bachoud-Levi, A., Authier, F. & Itti, E. (2016). FDG-PET/CT Brain Findings in a Patient With Macrophagic Myofasciitis. Nuclear medicine and molecular imaging, 50(1), 80-4. doi:10.1007/s13139-015-0371-z

Fenelon, G., Soulas, T., Cleret de Langavant, L., Trinkler, I. & Bachoud-Levi, A. (2011). Feeling of presence in Parkinson's disease. Journal of neurology, neurosurgery, and psychiatry, 82(11), 1219-24. doi:10.1136/jnnp.2010.234799

Bachoud-Levi, A., Hantraye, P. & Peschanski, M. (2002). Fetal neural grafts for Huntington's disease: a prospective view. Movement disorders : official journal of the Movement Disorder Society, 17(3), 439-44. doi:10.1002/mds.10117

Matthys, A., Seddik, L. , Djellaoui, A. , Faugeras, F., Abdelhedi, J. , Petit, A. , Boyer, J. , Montillot, J., Hosseini, H. & Bachoud-Levi, A. (2020). Forme inflammatoire d’angiopathie amyloïde : à propos d’un cas. Revue Neurologique, 176, S71-S72

Drouot, X., Oshino, S., Jarraya, B., Besret, L., Kishima, H., Remy, P., Dauguet, J., Lefaucheur, J., Dollé, F., Condé, F., Bottlaender, M., Peschanski, M., Keravel, Y., Hantraye, P. & Palfi, S. (2004). Functional recovery in a primate model of Parkinson's disease following motor cortex stimulation. Neuron, 44(5), 769-78. doi:10.1016/j.neuron.2004.11.023

Douaud, G., Gaura, V., Ribeiro, M., Lethimonnier, F., Maroy , R., Verny, C., Krystkowiak, P., Damier, P., Bachoud-Levi, A., Hantraye, P. & Remy, P. (2006). Grey matter atrophy in Huntington disease: a combined ROI-based and voxel-based morphometric study. NeuroImage(104), 10661-10666

Désaméricq, G., Youssov, K., Charles, P., Saleh, N., Olivier, A., Sherer-Gagou, C. & Verny, C. (2016). Guidelines for clinical pharmacological practices in Huntington's disease. Rev Neurol (Paris), 172(8-9), 423-432. doi:10.1016/j.neurol.2016.07.012

Cleret de Langavant, L., Trinkler, I., Cesaro, P. & Bachoud-Levi, A. (2009). Heterotopagnosia: When I point at parts of your body. Neuropsychologia, 47(7), 1745-55. doi:10.1016/j.neuropsychologia.2009.02.016

Saleh, N., Moutereau, S., Azulay, J., Verny, C., Simonin, C., Tranchant, C., El Hawajri, N., Bachoud-Levi, A. & Maison, P. (2010). High insulinlike growth factor I is associated with cognitive decline in Huntington disease. Neurology. doi:10.1212/WNL.0b013e3181e62076

Villafane, G., Thiriez, C., Audureau, E., Straczek , C., Kerschen, P., Cormier-Dequaire , F., Van Der Gucht, A., Gurruchaga, J., Evangelista, E., Defer, G., Damier, P., Remy, P., Itti, E., Fenelon, G. & Quéré-Carne M, M. (2017). High-dose transdermal nicotine in Parkinson's disease patients: a randomized, open-label, blinded-endpoint evaluation phase 2 study. Eur J Neurol , 25, 120-127. doi:10.1111/ene.13474

Squitieri, F., Gellera, C., Cannella, M., Mariotti, C., Cislaghi, G., Rubinsztein, D., Almqvist, E., Turner, D., Bachoud-Levi, A., Simpson, S., Delatycki, M., Maglione, V., Hayden, M. & Donato, S. (2003). Homozygosity for CAG mutation in Huntington disease is associated with a more severe clinical course. Brain : a journal of neurology, 126(Pt 4), 946-55.

Schramm, C., Katsahian, S., Youssov, K., Démonet, J., Krystkowiak, P., Supiot, F., Verny, C., Cleret de Langavant, L. & Bachoud-Levi, A. (2015). How to Capitalize on the Retest Effect in Future Trials on Huntington’s Disease. PLoS ONE. doi:10.1371/journal.pone.0145842

Bachoud-Levi, A., (Et Al), . & Cleret de Langavant, L. (2020). Human Fetal Cell Therapy in Huntington's Disease: A Randomized, Multicenter, Phase II Trial. Movement disorders, 35(8), 1323-1335. doi:10.1002/mds.28201

De Gelder, B., Van Den Stock, J., Balaguer Rde, D. & Bachoud-Levi, A. (2008). Huntington's disease impairs recognition of angry and instrumental body language. Neuropsychologia, 46(1), 369-73. doi:10.1016/j.neuropsychologia.2007.10.015

Moss, D., Pardiñas , A., Langbehn, D., Leavitt, B., Roos, R., Durr, A., Mead, S., Track-Hd, i., Registry, i., Holmans, P., Jones, L., Tabrizi, S. & Bachoud-Levi, A. (2017). Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study. Lancet Neurol., 16(9), 701-711. doi:10.1016/S1474-4422(17)30161-8